Management of side effects of antidepressants - Brief review of recomendations from guidelines for treatment of major depressive disorder

Psychiatria Danubina

Volumn 21, Issue 1, 2009, Pages 91-94

  Uzun, Suzana ^a   Kozumplik, Oliver ^a  

^a Referentni centar za Alzheimerovu bolest i psihijatriju sta rijeivo t ne dobi   (Croatia)

Author keywords

Antidepressants; Major depressive disorder; Side effects; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DRUG MONITORING; DRUG THERAPY, COMBINATION; HUMANS; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 63649144484     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157: 1-45.
2. Bauer M, Whybrow PC, Angst J, Versiani M & Möller HJ, WTSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders: World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder. World J Biol Psychiatry 2002; 3:5-43.
3. Bauer M, Whybrow PC, Angst J, Versiani M & Möller HJ, WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders: World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance Treatment of Major Depressive Disorder and Treatment qf Chronic Depressive Disorders and Subthreshold Depressions. World J Biol Psychiatry 2002; 3:69-86.
4. Gartlehner G, Thieda P, Hansen RA, Gaynes BN, Deveaugh-Geiss A, Krebs EE & Lohr KN: Comparative risk for harms of second-generation antidepressants: a systematic review and meta-analysis. Drug Saf. 2008; 31:851-65.
5. Hansen HV & Kessing LV: Adherence to antidepressant treatment. Expert Rev Neurother. 2007; 7:57-62.
6. National Institute for Clinical Excellence: Depression: management of depression in primary and secondary care. London: NICE, 2004. (National Clinical Practice Guideline No 23.)
7. Qaseem A, Snow V, Denberg TD, Forciea MA & Owens DK: Clinical Efficacy Assessment Subcommittee of American College of Physicians: Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008; 149:725-33.
8. Ten Doesschate MC, Bockting CL & Schene AH: Adherence to continuation and maintenance antidepressant use in recurrent depression. J Affect Disord. 2008. [Epub ahead of print]